Haleon Projects Strong 2024 Performance Despite Sluggish Q1 Outlook

After a robust 2023, Haleon anticipates 4%-6% organic revenue growth in 2024, with share buybacks and debt reduction highlighting financial strength.

Haleon's FY 2023 revenues rose 4.1% to £11.3 billion, with organic growth of 8%, driven by price increases and volume improvements.
The company plans a £500 million share buyback in 2024, following a significant debt reduction from £9.9 billion to £8.5 billion.
Despite a tepid cold and flu season and cooling demand in China, Haleon maintains a positive outlook for 2024, expecting organic revenue growth of 4%-6%.
Haleon's first-quarter 2024 revenue growth is projected to be just below 4%, due to strong comparatives from the previous year.
The company's focus on high-growth brands and portfolio optimization, including the sale of Lamisil and ChapStick, supports its medium-term targets.